Radioligand Therapy (RLT) Academy
As part of a pan-European consortium managed by the RPP Agency, the EANM and its partners recently were awarded an Erasmus+ grant to build a Radioligand Therapy (RLT) Academy. This initiative is a first-of-its-kind European-level training opportunity. Over 30 months, the EANM will co-shape the academy with its consortium partners. These partners include leading institutions in the field and the EAU as a clinical partner. Furthermore, the academy is supported by the European Oncology Nursing Society (EONS), Advanced Accelerator Applications (AAA) and the International Atomic Energy Agency (IAEA), which act as associate partners.